Added to YB: 2024-10-14
Pitch date: 2024-10-14
KZR [bullish]
Kezar Life Sciences, Inc.
-26.98%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
Market Cap
$45.1M
Pitch Price
$8.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.61
P/E
-0.64
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
KEZAR LIFE SCIENCES KZR
A summary for this pitch has not been created yet.
Read full article (0 min)